Federal health regulators have rejected an application filed by Acadia Pharmaceuticals to expand the use of its blockbuster antipsychotic drug, Nuplazid, highlighting concerns that the medication may not be effective among certain subgroups of dementia patients.…
Public Citizen is calling for an investigation into the relationship between the FDA and Biogen after the agency helped shepherd an experimental Alzheimer’s disease drug through its approval process despite clinical trials being cancelled due to its ineffectiveness.…
Older adults who are exposed to air pollution may experience brain shrinkage consistent with Alzheimer’s disease, even when the exposure is at levels that are generally considered “safe”, according to the findings of a new study that highlights the importance of taking steps to modify the risk factor.…
A new study indicates concussions can lead to a variety of long-term mental disorders.…
A new study indicates that hormone replacement therapy may be linked to a small increased risk of Alzheimer’s disease.…
The FDA is warning against the practice of receiving plasma infusions from young donors to prevent conditions associated with aging, because they have not been proven safe or effective and are not approved medical treatments.…
A JAMA editorial calls on doctors and consumers to combat “pseudomedicine” claims of dietary supplements that allegedly promote brain health and claim to treat dementia, Alzheimer’s and other illnesses.…
A new study questions previous findings that linked Nexium and similar drugs to an increased risk of dementia.…
An Alzheimer’s disease misdiagnosis lawsuit has been filed against a Toledo clinic and doctor after more than 50 patients were allegedly told they had the degenerative disease when they did not, by a doctor who was not licensed.…
Pollution from nearby roads may increase the risk of dementia, according to the findings of a new study.…
